Artikel
Tetanus Quick Stik – is the NHS missing a trick?
Suche in Medline nach
Autoren
Veröffentlicht: | 6. Februar 2020 |
---|
Gliederung
Text
Objectives/Interrogation: Lacerations and open hand fractures make up a significant proportion of admissions under hand surgeons. These patients require determination of tetanus immunity to allow prophylaxis if deemed at risk of contamination. Studies show that 57% of patients are unable to recall seroprotection status. The "Tetanos Quick Stik®" (TQS) is a 10-minute bedside test for tetanus immunity that boasts 100% specificity and 80% sensitivity. We aimed to identify the potential cost saving of the TQS at a tertiary plastic surgery centre.
Methods: Retrospective literature searches of EMBASE, Medline, Pubmed and Google Scholar were conducted. Search terms included "tetanos quick stik", "tetanus prophylaxis" and "cost analysis". Financial data on tetanus prophylaxis was collected from the clinical coding and pharmacy departments. Published statistics were then applied to our hospital data.
Results and Conclusions: Studies have demonstrated that TQS can avoid treatment with vaccine or tetanus immunoglobulin (TIG) in 77% of patients. Our hospital spent £21,376 over the financial year 2017/18 on vaccine doses and TIG. Using published data, we have identified a potential cost saving of £7162.18 (34%) in our centre alone and £8,929.86 across the whole trust.
The TQS is a cost effective bedside tool, available on NHS Supply Chain, that has potential to make significant cost savings in the NHS. We have developed a protocol that is being implemented in our trust for tetanus prophylaxis in the ED.